Cargando…

Immunosenescence-Related Transcriptomic and Immunologic Changes in Older Individuals Following Influenza Vaccination

The goal of annual influenza vaccination is to reduce mortality and morbidity associated with this disease through the generation of protective immune responses. The objective of the current study was to examine markers of immunosenescence and identify immunosenescence-related differences in gene ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Kennedy, Richard B., Ovsyannikova, Inna G., Haralambieva, Iana H., Oberg, Ann L., Zimmermann, Michael T., Grill, Diane E., Poland, Gregory A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089977/
https://www.ncbi.nlm.nih.gov/pubmed/27853459
http://dx.doi.org/10.3389/fimmu.2016.00450
_version_ 1782464326615957504
author Kennedy, Richard B.
Ovsyannikova, Inna G.
Haralambieva, Iana H.
Oberg, Ann L.
Zimmermann, Michael T.
Grill, Diane E.
Poland, Gregory A.
author_facet Kennedy, Richard B.
Ovsyannikova, Inna G.
Haralambieva, Iana H.
Oberg, Ann L.
Zimmermann, Michael T.
Grill, Diane E.
Poland, Gregory A.
author_sort Kennedy, Richard B.
collection PubMed
description The goal of annual influenza vaccination is to reduce mortality and morbidity associated with this disease through the generation of protective immune responses. The objective of the current study was to examine markers of immunosenescence and identify immunosenescence-related differences in gene expression, gene regulation, cytokine secretion, and immunologic changes in an older study population receiving seasonal influenza A/H1N1 vaccination. Surprisingly, prior studies in this cohort revealed weak correlations between immunosenescence markers and humoral immune response to vaccination. In this report, we further examined the relationship of each immunosenescence marker (age, T cell receptor excision circle frequency, telomerase expression, percentage of CD28(−) CD4(+) T cells, percentage of CD28(−) CD8(+) T cells, and the CD4/CD8 T cell ratio) with additional markers of immune response (serum cytokine and chemokine expression) and measures of gene expression and/or regulation. Many of the immunosenescence markers indeed correlated with distinct sets of individual DNA methylation sites, miRNA expression levels, mRNA expression levels, serum cytokines, and leukocyte subsets. However, when the individual immunosenescence markers were grouped by pathways or functional terms, several shared biological functions were identified: antigen processing and presentation pathways, MAPK, mTOR, TCR, BCR, and calcium signaling pathways, as well as key cellular metabolic, proliferation and survival activities. Furthermore, the percent of CD4(+) and/or CD8(+) T cells lacking CD28 expression also correlated with miRNAs regulating clusters of genes known to be involved in viral infection. Integrated (DNA methylation, mRNA, miRNA, and protein levels) network biology analysis of immunosenescence-related pathways and genesets identified both known pathways (e.g., chemokine signaling, CTL, and NK cell activity), as well as a gene expression module not previously annotated with a known function. These results may improve our ability to predict immune responses to influenza and aid in new vaccine development, and highlight the need for additional studies to better define and characterize immunosenescence.
format Online
Article
Text
id pubmed-5089977
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-50899772016-11-16 Immunosenescence-Related Transcriptomic and Immunologic Changes in Older Individuals Following Influenza Vaccination Kennedy, Richard B. Ovsyannikova, Inna G. Haralambieva, Iana H. Oberg, Ann L. Zimmermann, Michael T. Grill, Diane E. Poland, Gregory A. Front Immunol Immunology The goal of annual influenza vaccination is to reduce mortality and morbidity associated with this disease through the generation of protective immune responses. The objective of the current study was to examine markers of immunosenescence and identify immunosenescence-related differences in gene expression, gene regulation, cytokine secretion, and immunologic changes in an older study population receiving seasonal influenza A/H1N1 vaccination. Surprisingly, prior studies in this cohort revealed weak correlations between immunosenescence markers and humoral immune response to vaccination. In this report, we further examined the relationship of each immunosenescence marker (age, T cell receptor excision circle frequency, telomerase expression, percentage of CD28(−) CD4(+) T cells, percentage of CD28(−) CD8(+) T cells, and the CD4/CD8 T cell ratio) with additional markers of immune response (serum cytokine and chemokine expression) and measures of gene expression and/or regulation. Many of the immunosenescence markers indeed correlated with distinct sets of individual DNA methylation sites, miRNA expression levels, mRNA expression levels, serum cytokines, and leukocyte subsets. However, when the individual immunosenescence markers were grouped by pathways or functional terms, several shared biological functions were identified: antigen processing and presentation pathways, MAPK, mTOR, TCR, BCR, and calcium signaling pathways, as well as key cellular metabolic, proliferation and survival activities. Furthermore, the percent of CD4(+) and/or CD8(+) T cells lacking CD28 expression also correlated with miRNAs regulating clusters of genes known to be involved in viral infection. Integrated (DNA methylation, mRNA, miRNA, and protein levels) network biology analysis of immunosenescence-related pathways and genesets identified both known pathways (e.g., chemokine signaling, CTL, and NK cell activity), as well as a gene expression module not previously annotated with a known function. These results may improve our ability to predict immune responses to influenza and aid in new vaccine development, and highlight the need for additional studies to better define and characterize immunosenescence. Frontiers Media S.A. 2016-11-02 /pmc/articles/PMC5089977/ /pubmed/27853459 http://dx.doi.org/10.3389/fimmu.2016.00450 Text en Copyright © 2016 Kennedy, Ovsyannikova, Haralambieva, Oberg, Zimmermann, Grill and Poland. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Kennedy, Richard B.
Ovsyannikova, Inna G.
Haralambieva, Iana H.
Oberg, Ann L.
Zimmermann, Michael T.
Grill, Diane E.
Poland, Gregory A.
Immunosenescence-Related Transcriptomic and Immunologic Changes in Older Individuals Following Influenza Vaccination
title Immunosenescence-Related Transcriptomic and Immunologic Changes in Older Individuals Following Influenza Vaccination
title_full Immunosenescence-Related Transcriptomic and Immunologic Changes in Older Individuals Following Influenza Vaccination
title_fullStr Immunosenescence-Related Transcriptomic and Immunologic Changes in Older Individuals Following Influenza Vaccination
title_full_unstemmed Immunosenescence-Related Transcriptomic and Immunologic Changes in Older Individuals Following Influenza Vaccination
title_short Immunosenescence-Related Transcriptomic and Immunologic Changes in Older Individuals Following Influenza Vaccination
title_sort immunosenescence-related transcriptomic and immunologic changes in older individuals following influenza vaccination
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089977/
https://www.ncbi.nlm.nih.gov/pubmed/27853459
http://dx.doi.org/10.3389/fimmu.2016.00450
work_keys_str_mv AT kennedyrichardb immunosenescencerelatedtranscriptomicandimmunologicchangesinolderindividualsfollowinginfluenzavaccination
AT ovsyannikovainnag immunosenescencerelatedtranscriptomicandimmunologicchangesinolderindividualsfollowinginfluenzavaccination
AT haralambievaianah immunosenescencerelatedtranscriptomicandimmunologicchangesinolderindividualsfollowinginfluenzavaccination
AT obergannl immunosenescencerelatedtranscriptomicandimmunologicchangesinolderindividualsfollowinginfluenzavaccination
AT zimmermannmichaelt immunosenescencerelatedtranscriptomicandimmunologicchangesinolderindividualsfollowinginfluenzavaccination
AT grilldianee immunosenescencerelatedtranscriptomicandimmunologicchangesinolderindividualsfollowinginfluenzavaccination
AT polandgregorya immunosenescencerelatedtranscriptomicandimmunologicchangesinolderindividualsfollowinginfluenzavaccination